Trade PMN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
ProMIS Neurosciences Inc. Common Shares (ON) (PMN) is trading at US$13.56, up 1.19% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$130.12M. Over the past 52 weeks, PMN has traded between US$6.27 and US$27.40. On Syfe you can trade PMN with $0 commission and add it to your watchlist.
| Previous close | US$13.40 |
|---|---|
| Market cap | US$130.12M |
| 52-week range | US$6.27 – US$27.40 |
| Volume | 19.95K |
| Exchange | US |
Add to Watchlist
Set Price Alert
ProMIS Neurosciences Inc. Common Shares (ON)
ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease. The company was founded by Neil Cashman and Vigen Nazarian on January 23, 2004 and is headquartered in Toronto, Canada.
Year: 2005
Chardan Adjusts Price Target on ProMIS Neurosciences to $33 From $20, Maintains Buy Rating
Jul 28, 2:46 PM · MT Newswires
ProMIS Neurosciences Says PMN310 Alzheimer Drug Shows Positive Interim Safety, Biomarker Data
Jul 28, 12:19 PM · MT Newswires
Chardan Initiates ProMIS Neurosciences at Buy With $20 Price Target
Jul 27, 10:35 AM · MT Newswires
ProMIS Neurosciences Says PMN310 Reduced Amyloid-Beta Oligomers in Phase 1a Study
Jul 14, 7:48 AM · MT Newswires
Cantor Fitzgerald Initiates ProMIS Neurosciences at Overweight
Jun 30, 10:02 AM · MT Newswires
Stay on top of PMN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
